HIRA

필수의약품 안정적 공급을 위한 관리체계 연구(퇴장방지의약품제도 중심으로)

  • 31
  • 38
Metadata Downloads
Type
Research report
Author(s)
김주영이정아김민수김예슬
Issued Date
2025-01
Keyword
퇴장방지의약품필수의약품원가 보전
Publisher
건강보험심사평가원
URI
https://repository.hira.or.kr/handle/2019.oak/3457
Table Of Contents
요약 ······························································································ 1
제1장 서론
1. 연구 배경 ······························································································ 3
2. 연구 목적 ······························································································ 5
3. 연구 내용 및 방법 ·················································································· 5
제2장 의약품 공급 불안정 심화: 원인, 영향 및 국가별 대응
1. WHO 및 주요 국가별 의약품 공급 중단·부족 정의 ··································· 9
2. 주요 국가별 필수의약품 공급 부족 현황 및 원인 ····································· 11
3. 의약품 공급 안정화를 위한 주요 국가별 정책 대응 ·································· 17
4. 소결 ···································································································· 26
제3장 필수의약품 제도
1. WHO 필수의약품 ··············································································· 29
2. 국가필수의약품 ··················································································· 36
제4장 퇴장방지의약품제도
1. 퇴장방지의약품제도 ··············································································· 55
2. 퇴장방지의약품제도 관련 선행연구 고찰 ·················································· 69
3. 일본의 퇴장방지의약품제도 운영 현황 ····················································· 75
4. 소결 ···································································································· 87
제5장 퇴장방지의약품 현황
1. 퇴장방지의약품 품목 수 및 청구 현황 ···················································· 91
2. 퇴장방지의약품 상한금액 분포 ······························································· 99
3. 퇴장방지의약품 생산 공급 중단 보고 품목 현황 ····································· 106
4. 소결 ·································································································· 110
제6장 퇴장방지의약품 원가산정방식 및 적용기준 개선 방안
1. 현행 퇴장방지의약품 원가산정방식 및 적용기준 ····································· 113
2. 최근 3개년 퇴장방지의약품 원가보전 제출 자료 확인 ····························· 122
3. 시나리오 설정 및 분석 ········································································ 124
4. 개선안별 제출 서류 및 소요 공수 ························································ 129
5. 기타 고려 사항 ·················································································· 135
제7장 퇴장방지의약품제도 개선 방안
1. 현행 제도 고찰 ·················································································· 143
2. 한국제약바이오협회 건의안 ································································· 144
3. 퇴장방지의약품제도 개선안 ·································································· 145
제8장 결론 및 제언
1. 결론 ·································································································· 187
2. 제언 ·································································································· 187
◾ 참고 문헌 ····················································································· 193
◾ 부록 ····························································································· 199
◾ ABSTRACT ················································································· 219
Publisher
건강보험심사평가원
Location
KOR
Citation
김주영. (2025-01). 필수의약품 안정적 공급을 위한 관리체계 연구(퇴장방지의약품제도 중심으로).
Appears in Collections:
HIRA 연구 > 1. 자체연구
공개 및 라이선스
  • 공개 구분공개
파일 목록

열람하신 정보에 대해 만족하십니까?

기타의견

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.